Literature DB >> 30076921

Mechanism mediating the protective effect of diacerein in ischemia-reperfusion-induced testicular injury in rats.

Seham A Abdel-Gaber1, Rehab K Mohammed2, Marwa M M Refaie3.   

Abstract

AIMS: Torsion of the spermatic cord is a common urologic emergency and can lead to testicular necrosis and infertility. Diacerein (DIA) is interleukin-1b (IL-1b) blocker which has a protective role against myocardial ischemia-reperfusion, however, to-date this role has not been investigated in testicular ischemia- reperfusion (TIR). We aimed to investigate the role and mechanism of action of DIA in induced TIR. MAIN
METHODS: DIA (50 mg/kg) was administered i.m (intramuscular) to rats in the presence or absence of TIR. Testicular weight changes and serum testosterone and total cholesterol levels were evaluated. In addition; the level of testicular tissue reduced glutathione (GSH), malondialdehyde (MDA), total nitrites (NOx) and the activity of superoxide dismutase (SOD) were measured. Histopathology and interleukin1b (IL-1b) immunoexpression were evaluated. KEY
FINDINGS: TIR manifested by significant decrease in testicular weight, serum testosterone and testicular tissue GSH levels and SOD activity as well as increase in serum total cholesterol, testicular MDA and NOx levels. TIR showed the histopathological changes of marked testicular damage with increase in IL-1b immunoexpression. DIA was able to normalize both testicular weight, serum testosterone and cholesterol levels with attenuation of oxidative stress parameters along with amelioration of histopathological changes and IL-1 b immunostaining induced by TIR. SIGNIFICANCE: DIA has a protective effect against TIR induced injury in rats mediated by its anti-inflammatory and anti-oxidant activities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diacerein; Histopathology; Immunoexpression; Inflammation; Oxidative stress; Testicular ischemia-reperfusion

Mesh:

Substances:

Year:  2018        PMID: 30076921     DOI: 10.1016/j.lfs.2018.07.060

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Diacerein, an inhibitor of IL-1β downstream mediated apoptosis, improves radioimmunotherapy in a mouse model of Burkitt's lymphoma.

Authors:  Javeria Zaheer; A Ram Yu; Hyeongi Kim; Hyun Ji Kang; Min Kyoung Kang; Jae Jun Lee; Jin Su Kim
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2021-12       Impact factor: 4.304

Review 3.  The NLRP3 inflammasome: molecular activation and regulation in spermatogenesis and male infertility; a systematic review.

Authors:  Marziyeh Tavalaee; Mohsen Rahmani; Joël R Drevet; Mohammad Hossein Nasr-Esfahani
Journal:  Basic Clin Androl       Date:  2022-05-30

4.  Ameliorative effects of silymarin on HCl-induced acute lung injury in rats; role of the Nrf-2/HO-1 pathway.

Authors:  Rasha F Ahmed; Rabab A Moussa; Reda S Eldemerdash; Mahmoud M Zakaria; Seham A Abdel-Gaber
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

5.  Picroside II attenuates ischemia/reperfusion testicular injury by alleviating oxidative stress and apoptosis through reducing nitric oxide synthesis.

Authors:  Yanze Li; Lei Wang; Zhiyuan Chen; Xiuheng Liu
Journal:  Acta Cir Bras       Date:  2019-12-20       Impact factor: 1.388

6.  Impaired macrophages and failure of steroidogenesis and spermatogenesis in rat testes with cytokines deficiency induced by diacerein.

Authors:  Salmo Azambuja de Oliveira; Paulo Sérgio Cerri; Estela Sasso-Cerri
Journal:  Histochem Cell Biol       Date:  2021-09-13       Impact factor: 4.304

7.  Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-κB and upregulating PPAR-γ signal.

Authors:  Gellan Alaa Mohamed Kamel; Eman Harahsheh; Shaimaa Hussein
Journal:  Mol Biol Rep       Date:  2022-04-02       Impact factor: 2.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.